A rare case of familial methylmalonic acidemia presenting with Acrodermatitis Enteropathica type of lesion

Wali P.P1, Parakh H2, Reddy P 3

1Dr. Pradnya P. Wali, Junior Consultant Neonatologist, 2Dr. Hemant Parakh, Consultant Neonatologist, 3Dr. Prashant Reddy, Consultant Pediatricians, Sunrise Children Hospital, Hyderabad, AP, India

Address for Correspondence: Dr. Pradnya P. Wali, Email: drpradnyawali@gmail.com



Abstract

Methylmalonic academia (MMA) is an inborn error of metabolism commonly presenting in newborns with an occurrence of 1 in 50,000 to 80,000 newborns. It has autosomal recessive mode of inheritance. It is a disorder of amino acid metabolism. MMA occurs due to defective conversion of methylmalonyl-coenzyme A (CoA) to succinyl-CoA. It presents early at around 1 month to 1 year of age. It has predominat neurologic manifestations such as seizures, developmental delay, encephalopathy, and stroke. However due to malabsorption of zinc and secondary deficiency of branched chain aminoacids it rarely presents as Acrodermatitis Enteropathica. Here we report a case of a 5 months old girl with familial MMA presenting with skin eruptions typical of Acrodermatitis Enteropathica.

Keywords: Methylmalonic Acidemia, Acrodermatitis Enteropathica, Inborn error of metabolism



Manuscript received: 5th April 2017, Reviewed: 15th April 2017
Author Corrected: 23rd April 2017, Accepted for Publication: 30th April 2017

Case Report

A 5 month old baby girl presented to our hospital with history of loose stools lasting for 15 days. She was lethargic and noted to have skin lesions. On analyzing her history she was born out of second degree consanguineous parents. She lost her sibling at 4 months who was diagnosed as sepsis with developmental delay. There was history of two neonatal deaths in her paternal side with similar complaints.

On admission she was sick, dehydrated &lethargic. She had severe chelitis & prominent skin lesions over trunk, perioral & perianal region. She had poor weight gain, hypotonia & severe microcephaly; Head circumference being 35 cms at 5 months of age. She had developmental delay was present with partial neck holding & was not able to rollover. Her initial investigations revealed anemia (Hb-6.8g/dl, Hct-20.7,TLC-5000/cu.mm, platelets-1.5 lakhs/cu.mm, hypernatremia Na+: 150mmol/L).

She was treated with intravenous fluids, antibiotics & other supportive measures. She was given blood transfusion. With history of consanguinity among her parents with family history of neonatal deaths, Inborn error of metabolism was suspected. Tandem Mass Spectroscopy & Gas Chromatography were planned. Mass Spectroscopy was positive for methylmalonic acidemia. Magnetic Resonance imaging of BRAIN was suggestive of neurometabolic disorder. She was started on carnitine supplementation, calorie rich diet, protein restriction, special metanutrition formula along with cobalamin supplementation.

Her skin lesions did not improve with clotrimazole. Acrodermatitis enteropathica like lesions were confirmed by clinical signs & she was started on zinc supplementation following which she showed signs of improvement. Genetic counseling was done. She is on follow up with good recovery.

Discussion

Methylmalonic academia (MMA) is an inborn error of metabolism commonly presenting in newborns with an occurrence of 1 in 50,000 to 80,000 newborns [1]. It has autosomal recessive mode of inheritance. It is a disorder of amino acid metabolism. MMA occurs due to defective conversion of methylmalonyl-coenzyme A (CoA) to succinyl-CoA.
 
It presents early at around 1 month to 1 year of age. It has predominat neurologic manifestations such as seizures, developmental delay, encephalopathy, and stroke [2,3]. However due to malabsorption of zinc and secondary deficiency of branched chain aminoacids it rarely presents as Acrodermatitis enteropathica [4]. As Methylmalonyl-coA is associated with metabolism of isoleucine, valine, threonine and methionine, disorders of these aminoacids also affects Methylmalonyl-coA [5]. It is predominant in areas with high rates of consanguineous marriages [6]. MMA affects both males and females equally.
Genetics:

figure01
Fig 1: Autosomal recessive inheritance pattern in MMA

In our case there was strong family history with previous sibling death due to developmental delay & respiratory failure. Even two of the fathers cousins who had consanguinity had affected children who died in infancy due to similar complaints. All affected siblings were female. No genetic testing or detail metabolic analysis was done in those infants.

Severe nutritional deficiency of vitamin B12 can also result in similar features like MMA [7]. MMA presents usually in first year of life. Clinical features include Vomiting, dehydration, lethargy, recurrent infections, failure to thrive, hepatosplenomegaly, seizures, encephalopathy, stroke. Skin eruptions similar to acrodermatitis enteropathica may occur in MMA [8, 9] causing skin inflammation in extremities, perioral & perianal region. Low protein diet strictly limited in branched chain aminoacids, mostly isoleucine may result in cutaneous lesions.
    
figure02    figure03
Fig 2: Picture showing cutaneous lesions similar to Acrodermatitis enteropathica in a child with MMA

Complete blood cell (CBC) counts, Serum Electrolytes, RFT, ABG are the initial line of investigations. TMS & GCMS confirms the diagnosis. Neutropenia, anemia, thrombocytopenia & metabolic acidosis are noted. There is raised levels of ammonia, glycine, and methylmalonic acid. Urinary levels of methylmalonic acid, methylcitrate, propionic acid & 3-hydroxypropionate levels are high. Magnetic resonance imaging (MRI) studies show bilateral lesions of the globus pallidus in patients with methylmalonic academia [10-13] along with delayed myelination, immature gyral pattern, microhemorrhages and periventricular white matter lesions
 
figure04  figure05
Fig 3: MRI Brain Showing Prominence of Extraventricular CSF Spaces Mainly in Fronto-temporal area &    Restricted diffusion in corpus callosum genu seen.

Medical management of methylmalonic acidemia includes protein-restricted diet with L-carnitine and cobalamin supplementation. Treatment of underlying infections is mandatory. Prognosis varies with the type of defect. There are 6 recognized defects in methylmalonate metabolism. cblA has the best prognosis whereas mut0 has the worst prognosis [14,15]. Patients with cobalamin-responsive disease may have better long-term prognosis .It is noted that early-onset cobalamin-nonresponders have the worst outcomes, with median survival of 6 years [16].

Conclusion

Prompt diagnosis with good clinical acumen of disorders of metabolism helps in better outcome. Understanding rare manifestations of such disorders with appropriate management is the cornerstone of management of metabolic disorders.

Funding: Nil, Conflict of interest: None initiated.
Permission from IRB: Yes

References
 

1. Hörster F, Hoffmann GF. Pathophysiology, diagnosis, and treatment of methylmalonic aciduria—recent advances and new challenges. Pediatric Nephrology. 2004;19 (10):1071-4.

2. Fenton WA, Rosenberg LE. Disorders of propionate and methylmalonate metabolism. Scriver CR, ed. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 1995. Vol 1: 1423-49.

3. Fenichel GM. Clinical Pediatric Neurology: A Signs and Systems Approach. 1996:12.

4. Lee S-Y, Jung Y-J, Oh TH, Choi EH. A case of acrodermatitis enteropathica localized on the hands and feet with a normal serum zinc level. Annals of dermatology. 2011;23(Suppl 1):S88-S90.

5. Matsui SM, Mahoney MJ, Rosenberg LE. The natural history of the inherited methylmalonic acidemias. New England Journal of Medicine. 1983 Apr 14;308(15):857-61.PMID:6132336 DOI: 10.1056/NEJM198304143081501.

6. Karam PE, Habbal MZ, Mikati MA, Zaatari GE, Cortas NK, Daher RT. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience. Clinical biochemistry. 2013;46(18):1787-92.

7. Higginbottom MC, Sweetman L, Nyhan WL (1978). "A syndrome of methylmalonic aciduria, homocystinuria, megaloblastic anemia and neurological abnormalities in a vitamin B12-deficient breast-fed infant of a strict vegetarian". N Engl J Med. 299 (7): 317–323. doi:10.1056/NEJM197808172990701. PMID 683264.

8. De Raeve L, De Meirleir L, Ramet J, Vandenplas Y, Gerlo E. Acrodermatitis enteropathica-like cutaneous lesions in organic aciduria. J Pediatr. 1994;124(3):416-20.

9. Lee JY, Chang SE, Suh CW, Choi JH, Sung KJ, Moon KC, et al. A case of acrodermatitis enteropathica-like dermatosis caused by ornithine transcarbamylase deficiency. Journal of the American Academy of Dermatology. 2002;46(6):965-7. [PubMed]

10. Heidenreich R, Natowicz M, Hainline BE, et al. Acute extrapyramidal syndrome in methylmalonic acidemia: "metabolic stroke" involving the globus pallidus. J Pediatr. 1988 Dec. 113(6):1022-7. [PubMed]

11. Korf B, Wallman JK, Levy HL. Bilateral lucency of the globus pallidus complicating methylmalonic acidemia. Ann Neurol. 1986 Sep. 20(3):364-6.

12. Larnaout A, Mongalgi MA, Kaabachi N, et al. Methylmalonic acidaemia with bilateral globus pallidus involvement: a neuropathological study. J Inherit Metab Dis. 1998 Aug. 21(6):639-44. [PubMed]

13. Brismar J, Ozand PT. CT and MR of the brain in disorders of the propionate and methylmalonate metabolism. AJNR Am J Neuroradiol. 1994 Sep. (8):1459-73.

14. Leonard JV, Walter JH, McKiernan PJ. The management of organic acidaemias: the role of transplantation. J Inherit Metab Dis. 2001 Apr. 24(2):309-11. [PubMed]

15. Brassier A, Boyer O, Valayannopoulos V, Ottolenghi C, Krug P, Cosson MA, et al. Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease. Mol Genet Metab. 2013 Sep-Oct. 110(1-2):106—1.

16. Nicolaides P, Leonard J, Surtees R. Neurological outcome of methylmalonic acidaemia. Arch Dis Child. 1998 Jun. 78(6):508-12.



How to cite this article?

Wali P. P, Parakh H, Reddy P. A rare case of familial methylmalonic acidemia presenting with Acrodermatitis Enteropathica type of lesion. Int J Med Res Rev 2017;5(04):438- 441. doi:10.17511/ijmrr. 2017.i04.10.